2008
DOI: 10.1016/j.tins.2007.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Critical issues of clinical human embryonic stem cell therapy for brain repair

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
135
0
3

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 177 publications
(139 citation statements)
references
References 66 publications
1
135
0
3
Order By: Relevance
“…Although later double-blind placebo-controlled trials reported no significant clinical benefits (38,39), successful cell replacement therapy in PD would probably be achieved with more sophisticated cell preparation, surgical and patient selection procedures (2,3). In particular, optimization of cell preparation has been an issue when using fetal tissue because of its limited availability and accessibility; thus, there is an urgent need to develop alternative cell sources (40). In addition, recent basic studies based on fetal tissue graft systems have suggested several potential refinements.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although later double-blind placebo-controlled trials reported no significant clinical benefits (38,39), successful cell replacement therapy in PD would probably be achieved with more sophisticated cell preparation, surgical and patient selection procedures (2,3). In particular, optimization of cell preparation has been an issue when using fetal tissue because of its limited availability and accessibility; thus, there is an urgent need to develop alternative cell sources (40). In addition, recent basic studies based on fetal tissue graft systems have suggested several potential refinements.…”
Section: Discussionmentioning
confidence: 99%
“…Others have also suggested that expression of DATs in the graft cells alleviates dyskinesias after graft (41). Therefore, proof-of-concept studies using fetal tissue grafts have established the direction of cell-based therapies, including those using stem cells (2,3,40). Particular concerns when…”
Section: Discussionmentioning
confidence: 99%
“…Yet, technical difficulties isolating neural stem cells (NSCs) and ethical concerns, among other issues, have limited the use of embryonic stem cells in clinical settings [1,2]. For example, transplanted embryonic stem cells can cause immune reactions and tumors that can damage healthy tissue [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…For example, transplanted embryonic stem cells can cause immune reactions and tumors that can damage healthy tissue [3][4][5]. In addition, the techniques that are traditionally used to grow and differentiate embryonic stem cells for therapeutic applications, cocultures with feeder cells, and=or a medium containing animal products are potentially harmful [1]. The ideal stem cell for clinical use would be isolated from the patient's own tissue.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation